💰 Dividend History

No dividend history available.

📅 Earnings & EPS History for Q

No earnings history available for this symbol.

📰 Related News & Research

• IQSTEL Inc. 2025 Annual Report: Telecom, Fintech, and AI Business Overview, Subsidiaries, and Global Operations 99
  April 7, 2026
  

  iQSTEL Inc. 2025 Annual Report: Key Highlights and Investor ...

• Titan Acquisition Corp. 2025 Annual Report Amendment: Financial Statements, Audit Correction, and SPAC Operations Overview
  April 7, 2026
  

  Titan Acquisition Corp. Files Amended 10-K: What Investors N...

• S&P 500 (+0.44%), Nasdaq (+0.54%), and Dow (+0.36%)
  April 6, 2026
  

  U.S. stocks rose modestly Monday, with the S&P 500 (+0.4...

• The Place Holdings Limited Responds to SGX Queries on FY2023 Annual Report: Disclosure, Board Diversity, and Director Commitments
  April 6, 2026
  

  The Place Holdings Limited: Detailed Response to SGX Queries...

• HC Surgical Specialists Acquires 51% of Chirurgia to Expand Minimally Invasive and HPB Surgery Services in Singapore
  April 6, 2026
  

  HC Surgical Specialists Acquires 51% Stake in Chirurgia Pte....

• HC Surgical Specialists Limited Acquires 51% Stake in Chirurgia Pte. Ltd. to Expand Minimally Invasive Surgery Services in Singapore
  April 6, 2026
  

  HC Surgical Specialists Limited: Strategic Acquisition of Ch...

• Anterix Inc. Announces New Contract and SEC Filing Details – Nasdaq Capital Market Listing and Company Information
  April 6, 2026
  

  Anterix Inc. Announces Milestone 900 MHz Spectrum Sale to No...

• Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion, Expands Rare Disease Portfolio With FDA-Approved VYKAT XR for Prader-Willi Syndrome 1
  April 6, 2026
  

  Neurocrine Biosciences to Acquire Soleno Therapeutics: In-De...

• Neurocrine Biosciences to Acquire Soleno Therapeutics for $2.9 Billion, Expanding Rare Disease Portfolio with VYKAT XR for Prader-Willi Syndrome
  April 6, 2026
  

  Neurocrine to Acquire Soleno Therapeutics for \$2.9 Billion ...

• Expand Energy Corporation Appoints Marcel Teunissen as Chief Financial Officer – NASDAQ EXE News April 2026 7
  April 6, 2026
  

  Expand Energy Corporation Appoints New CFO: Detailed Investo...

🔍 View more Reports